Bevacizumab and Malignant Glioma: Is there a Role for Upfront Therapy? (English)
- New search for: Wu, Jing
- New search for: R. Gilbert, Mark
- New search for: Wu, Jing
- New search for: R. Gilbert, Mark
In:
Controversies in Neuro-Oncology Volume 1
;
Chapter: 9
;
2012
- Article/Chapter (Book) / Electronic Resource
-
Title:Bevacizumab and Malignant Glioma: Is there a Role for Upfront Therapy?
-
Contributors:Wu, Jing ( author ) / R. Gilbert, Mark ( author )
-
Published in:Controversies in Neuro-Oncology Volume 1 ; Chapter: 9
-
Publisher:
- New search for: Bentham Science Publishers Ltd.
-
Publication date:2012
-
ISBN:
-
Type of media:Article/Chapter (Book)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents eBook
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
ContributorsC. Chen, Thomas / Chamberlain, Marc et al. | 2012
- 2
-
The Basic Science of Avastin (Bevacizumab) TherapyFlorence M. Hofman, Thomas C. Chen et al. | 2012
- 3
-
Avastin for Recurrent Malignant GliomasAnnick Desjardins, James J. Vredenburgh et al. | 2012
- 4
-
Avastin and Malignant Gliomas: Is there a Role?Teri N. Kreisl et al. | 2012
- 5
-
Bevacizumab with Hypofractionated Stereotactic Irradiation for Recurrent Malignant GliomasFabio M. Iwamoto, Philip H. Gutin et al. | 2012
- 6
-
Bevacizumab Failure in Patients with Recurrent Malignant GliomaAndrew D. Norden et al. | 2012
- 7
-
An Update on the Role of Anti-Angiogenic Therapy for Newly Diagnosed GlioblastomaDavid A. Reardon, Sith Sathornsumetee, James V. Vredenburgh et al. | 2012
- 8
-
Bevacizumab Plus Radiotherapy in Malignant Gliomas: Is there a Role?Minesh Mehta, Disha Patel, Arnab Chakravarti et al. | 2012
- 9
-
Bevacizumab and Malignant Glioma: Is there a Role for Upfront Therapy?Wu, Jing / R. Gilbert, Mark et al. | 2012
- 10
-
Bevacizumab Toxicity in GlioblastomaAregawi, Dawit / Schiff, David et al. | 2012
- 11
-
Is Bevacizumab Administration Safe When Combined with Therapeutic Anticoagulation in Patients with High-grade Glioma?Lisa R. Rogers et al. | 2012
- 12
-
Bevacizumab in the Treatment of Glioblastoma: Is there an Optimal Dose or Schedule?L. Kamsheh, P. Kumthekar, J. J. Raizer et al. | 2012
- 13
-
Assessing Radiographic Response in Glioblastoma Following Avastin TreatmentWhitney B. Pope et al. | 2012
- 14
-
The Radiographic Interpretation of Response to Avastin in Glioblastoma MultiformeButowski, Nicholas / Chang, Susan et al. | 2012
- 15
-
Imaging Responses of BevacizumabR. Thind, Y. S. Mohan, T. Mikkelsen et al. | 2012
- 16
-
Assessing Radiographic Response to Bevacizumab in Patients with GBMJohn W. Henson, Bart Keogh et al. | 2012
- 17
-
Neurosurgical Implications of Bevacizumab Therapy of Malignant GliomasManish K. Aghi, Mitchel S. Berger et al. | 2012
- 18
-
Neurosurgical Implications of AvastinGazanfar Rahmathulla, Michael A. Vogelbaum et al. | 2012
- 19
-
Novel Applications for Bevacizumab and other Angiogenic InhibitorsMarc C. Chamberlain et al. | 2012
- 20
-
Role of Avastin for Treatment of Central Nervous System Radiation NecrosisJing Wu, Victor A. Levin et al. | 2012
- 21
-
Salvage Chemotherapy with Bevacizumab for Recurrent Anaplastic GliomaMarc C. Chamberlain et al. | 2012
- 22
-
Bevacizumab for Recurrent Glioma - A Personal ViewRoger Stupp et al. | 2012
- 23
-
Inhibitors of VEGF Signaling Pathways in Glioblastoma: Is the Evidence Sufficient for Widespread Use? A European PerspectiveM. J. van den Bent et al. | 2012
- 24
-
Bevacizumab (Avastin®) and Malignant Glioma: Is there a Role? A European PerspectiveMichael Weller et al. | 2012
- 25
-
The European Perspective Regarding Avastin and Malignant GliomasWolfgang Wick, Michael Platten, Antje Wick et al. | 2012
- 26
-
Sunitinib for the Treatment of Central Nervous System GliomaNeyns Bart et al. | 2012
- 27
-
Cilengitide: A Novel Integrin Antagonist, in Malignant GliomaL. Burt Nabors et al. | 2012
- 28
-
Development of Sorafenib in Malignant Gliomas: Rationale and Early Clinical ExperienceRachel Grossman, Jaishri Blakeley et al. | 2012
- 29
-
Aflibercept (VEGF-Trap) in High-Grade GliomasDrappatz, Jan / D. Norden, Andrew / Y. Wen, Patrick et al. | 2012
- 30
-
Cediranib in GlioblastomaElizabeth R. Gerstner, Jorg H. Dietrich, Daphne Wang, Tracy T. Batchelor et al. | 2012
- 31
-
Bevacizumab for Malignant Gliomas: Comparative Study with Other MalignanciesHelen Gu, Thomas C. Chen et al. | 2012
- 32
-
Author IndexC. Chen, Thomas / Chamberlain, Marc et al. | 2012
- 33
-
IndexBentham Science Publishers et al. | 2012